A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: moving back (306), receding (2), withdrawing (86), thinning (200), losing ground (33), diminishing (17)

Carboplatin (AUC4)-Gemcitabine (day 1, 8) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1, 8) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1, 8) Retreat Indication • Recurrent
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday18Retreat.pdf

Carboplatin (AUC5) -Pegylated Liposomal Doxorubicin Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC5) – PEGYLATED LIPOSOMAL DOXORUBICIN (Caelyx) Retreat Please note this protocol is based on information for the
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/Carboplatin-AUC5-Pegylated-Liposomal-Doxorubicin-Retreat-Caelyx.pdf

Carboplatin (AUC6) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat Regimen (AUC6) • Ovary – Carboplatin (AUC6) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC6Retreat.pdf

Carboplatin (AUC5) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN Retreat (AUC5) Regimen • Ovary – Carboplatin (AUC5) Retreat Indication • Second line or subsequent treatment of platinum sensitive
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC5-Retreat.pdf

Carboplatin (AUC4)-Gemcitabine (day 1) Retreat

Description
Chemotherapy Protocol GYNAECOLOGICAL CANCER CARBOPLATIN (AUC4)-GEMCITABINE (day 1) Retreat Regimen • Ovary-Carboplatin (AUC4)-Gemcitabine (1) Indication • Recurrent platinum sensitive ovarian
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Ovarian-cancer/CarboplatinAUC4-Gemcitabineday1Retreat.pdf

Grant writing bursary scheme

Description
Information for prospective applicants on University Hospital Southampton R&D research grant writing bursary scheme What is the opportunity? Research Design
Url
/Media/Southampton-Clinical-Research/SoAR/Grant-writing-bursary-scheme.pdf

Getting-Help-July-21 (3)

Description
Getting Help All doctors struggle from time to time and working out what to do to help yourself can be
Url
/Media/UHS-website-2019/Docs/Health-professionals/Education/getting-help-july-21-3.docx

Capecitabine-Streptozocin

Description
Chemotherapy Protocol NEUROENDOCRINE CAPECITABINE-STREPTOZOCIN Regimen • Neuroendocrine – Capecitabine-Streptozocin Indication • Metastatic or locally advance neuroendocrine tumours irrespective of primary site, predominantly
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Endocrinecancer/Capecitabine-Streptozocin.pdf

Laryngeal papilloma - patient information

Description
This factsheet explains what laryngeal papilloma is, how it can affect you and what the available treatment options are.
Url
/Media/UHS-website-2019/Patientinformation/Ear-nose-and-throat/Laryngeal-papilloma-4001-PIL.pdf

Institutional information_2024-25

Description
Institutional information – key facts for inclusion as appropriate Support statements must be personal to your application to avoid the same document
Url
/Media/Southampton-Clinical-Research/Grants/Download/Institutional-information-2024-25.pdf
1 to 10 of 10